Papua New Guinea
Tuberculosis profile
Population  2012 7.2 million
Estimates of TB burden * 2012 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 3.9 (1.3–7.8) 54 (18–109)
Mortality (HIV+TB only) 0.24 (0.19–0.31) 3.4 (2.7–4.3)
Prevalence  (includes HIV+TB) 39 (13–77) 541 (187–1 079)
Incidence  (includes HIV+TB) 25 (16–35) 348 (230–490)
Incidence (HIV+TB only) 1.1 (0.71–1.5) 15 (9.9–21)
Case detection, all forms (%) 82 (59–120)    
TB case notifications 2012        
New cases   (%) Retreatment cases (%)
Smear-positive 2 862 (14) Relapse 223 (10)
Smear-negative 2 046 (10) Treatment after failure 95 (4)
Smear-unknown / not done 7 149 (35) Treatment after default 268 (12)
Extrapulmonary 8 277 (41) Other 1 568 (73)
Other 0 (0)      
Total new 20 334   Total retreatment 2 154  
           
Other (history unknown) 0        
Total new and relapse 20 557   Total cases notified 22 488  
New cases Smear-positive Smear-negative/ unknown/
not done
Extrapulmonary
M:F ratio 1.0    
Age < 15 109 3 020 2 520
Laboratories 2012
Smear (per 100 000 population) 1.6
Culture (per 5 million population) 0
Drug susceptibility testing (per 5 million population) 0
Is second-line drug susceptibility testing available? Yes, outside
country
Treatment success rate 2011 (%)        
New smear-positive and/or culture-positive 69   Is rifampicin used
throughout treatment for
new patients?
Yes
New smear-negative/extrapulmonary    
Retreatment 52  
TB/HIV 2012 Number (%)
TB patients with known HIV status 3 713 (17)
HIV-positive TB patients 364 (10)
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART) 325 (89)
HIV-positive people screened for TB 2 812  
HIV-positive people provided with IPT 325  
Estimates of MDR-TB burden 2012*   New   Retreatment
% of TB cases with MDR-TB 4.9 (3.6–6.1) 23 (20–27)
MDR-TB cases among notified pulmonary
TB cases
590 (430–740) 500 (420–590)
Reported cases of MDR-TB 2012 New Retreatment Total
Cases tested for MDR-TB     85
Laboratory-confirmed MDR-TB cases     58
Patients started on MDR-TB treatment     82
Financing TB control 2013
National TB programme budget (US$ millions) 11
% Funded domestically 70%
% Funded internationally 26%
% Unfunded 4%
***
(Rate per 100 000 population per year)
Mortality graph
___ Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
___ Prevalence

(Rate per 100 000 population per year)
Incidence graph
__ Notifications Incidence
___
___ Incidence (HIV+TB only)

Treatment success rate (%)
tx success graph
__ New smear-positive and/or culture-positive
__ New smear-negative/extrapulmonary __
Retreatment

(Number of patients)
CPT ART graph
__ HIV-positive TB patients
__ on CPT __ on ART

Total budget (US$ millions)
Budget funding Graph
__ Funded domestically __ Funded internationally
__ Unfunded
 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 * Ranges represent uncertainty intervals Generated: 2014-04-19 Data: www.who.int/tb/data